Product Quantum (Rs. Cr) Long Term Rating Short Term Rating
Bank Loan Ratings 9.00 ACUITE BB- | Stable | Upgraded -
Bank Loan Ratings 17.00 Not Applicable | Withdrawn -
Bank Loan Ratings 24.00 - ACUITE A4+ | Upgraded
Total Outstanding 33.00 - -
Total Withdrawn 17.00 - -
 
Rating Rationale

­Acuite has upgraded the long term rating to 'ACUITE BB-' (Read as ACUITE Double B Minus) from 'ACUITE B+' (Read as ACUITE B plus) and short term rating to 'ACUITE A4+' (Read as ACUITE A four plus) from 'ACUITE A4' (Read as ACUITE A Four) on Rs.33 crore of bank facilities of Food And Biotech Engineers India Private Limited (FBEIPL). The outlook is "Stable".
Acuite has also withdrawn the long-term facility of Rs.17 Crore  without assigning any rating as it is a proposed bank facility of Food And Biotech Engineers India Private Limited (FBEIPL). The rating has been withdrawn on account of the request received from the issuer. The rating withdrawal is in accordance with Acuité's policy on withdrawal of rating as applicable to the respective facility / instrument.

Rationale for upgrade:
The rating upgrade reflects FBEIPL’s long operational track record, experienced management, and established relationships with a diversified customer base across the food processing, dairy, FMCG, and beverage sectors, supported by a stable export presence. Revenue recorded a marginal improvement in FY25 but moderated in FY26 due to slower execution at the client’s end, driven by delays in inspection and site clearances. Operating Profitability has declined slightly in FY25 owing to higher raw material costs and the procurement of customer-specified equipment from the open market, which further compressed margins. However, margins are expected to improve slightly with the execution of higher-margin contracts. The company’s financial risk profile remains stable, supported by a comfortable capital structure and healthy coverage indicators. Liquidity, though stretched due to high utilization of fund-based limits and elevated gross current asset days, has improved in FY25 with better debtor, inventory, and other current asset levels. Acuité believes the company will continue to benefit from its established market presence, while sustaining profitability and efficiently managing working capital will remain key monitorable.


About the Company
Incorporated in the year 1999, Food And Biotech Engineers India Private Limited (FBEIPL) is a Delhi based company. The directors of the company are Mr. Rabindra Prasad Singh, Mr. Abhishek Singh Prasad and Mr. Anil Kumar Sinha. The company specializes in providing engineering, design, manufacturing, and services across various industries, including dairy , food processing, sugar, chemicals, and pharmaceuticals, with a particular focus on evaporators and dryers. 
 
Unsupported Rating
­Not Applicable
 
Analytical Approach

­Acuité has considered the standalone business and financial risk profiles Of Food and Biotech Engineers India Private Limited (FBEIPL) to arrive at this rating.

 
Key Rating Drivers

Strengths

Established track record of operations and experienced management
FBEIPL was incorporated in 1999, and the directors have over two decades of experience in the business line. This experience has supported the company in establishing relationships with its customers and suppliers. The company has a diversified customer base across the food processing, dairy, FMCG, and beverage sectors. Key clients include Gujarat Ambuja Exports Ltd., Hindustan Unilever Limited, Varun Beverages Limited, and Zydus Wellness Products Limited, along with dairy and cooperative entities such as Sonai Milk India Pvt. Ltd., Pearl Dairy Farms Ltd., West Assam Milk Producers Co-operative Union Ltd., and Bhopal Sahkari Dugdh Sangh Maryadit. The company also has an export presence in countries including Dubai, Uganda, South Africa, Australia, and Finland, which accounted for around 21% of revenues in FY25. Acuité believes that the company will continue to benefit from the experience of its directors and its relationships with customers and suppliers.

 Scale of operation:
FBEIPL recorded marginal revenue growth to Rs.114.08 crore in FY25 from Rs.103.03 crore in FY24, supported by improved execution during the year; however, revenue moderated to around Rs.90 crore in FY26 due to slower execution arising from delays at the client end in inspection and site clearances. As of March 2026, the company had an unexecuted order book of Rs.55.67 crore along with orders worth about Rs.90 crore under final negotiation, which is expected to support revenues over the medium term. Operating profitability witnessed moderation in FY25, with EBITDA margin declining to 3.80% from 4.28% in FY24 due to higher raw material costs and procurement from the open market, while PAT margin remained stood stable at 1.35% in FY25 compared to 1.38% in FY24. The company also has an export presence across multiple geographies, with transactions undertaken at spot rates without hedging. Management expects operating profitability to improve to around 4.50%–4.75% over the medium term, supported by the execution of relatively higher-margin contracts. Acuité believes that the operating performance of the company is likely to remain stable; however, the ability to sustain and improve profitability will remain a key monitorable going forward.

Moderate Financial Risk Profile:
The financial risk profile of the Company marked by average net worth, low gearing and moderate debt protection metrics. The total tangible net worth stood at Rs.27.87 crore in FY 25 as against Rs.26.33 crore in FY 24. Gearing stood at 0.36 times in FY 2025 as compared to 0.34 times in FY 24. Debt protection metrics stood stable with ICR and DSCR stood at 2.66 and 1.80 times in FY 25. TOL/TNW and Debt/EBITDA stood at 1.55 and 2.13 times in FY 25. Acuite believes financial risk profile expected to be stable over the medium term supported by absence of any significant debt funded capex plan.


Weaknesses

Intensive working capital Management with improvement:

Working capital remained intensive, though it improved in FY25, with GCA days declining to 184 days from 239 days in FY24, supported by improvement in debtor days, inventory days, and other current assets. Debtor days marginally improved to 119 days in FY25 from 129 days in FY24; however, receivables remained high due to the company’s collection structure, wherein 20–30% is received as advance, 50–60% after supply, and the balance 10–20% after installation. Further, around 55% of debtors were overdue beyond 180 days as of January 2026, as final payments are delayed in certain cases due to mandatory inspections and regulatory clearances. Inventory days reduced to 43 days in FY25 from 57 days in FY24, though average inventory holding remains around four months. Creditor’s days increased to 60 days in FY 25 days from 50 days in FY 24, in line with the company’s normal credit period. Other current assets declined sharply to Rs.6.64 crore in FY25 from Rs.15.18 crore in FY24, mainly due to lower advances to suppliers and reduced balances with revenue authorities, which also contributed to the improvement in the overall working capital cycle. Going forward, Acuité believes that working capital management may improve further with enhanced collection efficiency and tighter monitoring of receivables and inventory.

Highly competitive industry and cash flow dependent on timely execution of orders 
FBEIPL’s cash flows are exposed to the timely execution of the projects. There is an intensive competition from many organised and unorganised players of the industry. But the risk is mitigated by the intensive experience of the directors and long track record of operation. Acuite believes that it is critical for the company to execute orders in hand within stipulated timelines to sustain performance.

Rating Sensitivities

Potential triggers (individual or collective) for an upward rating action:
­Increase in scale of operation and EBITDA margin increasing to 4.50% or more
Improvement in collection efficiency
Potential triggers (individual or collective) for a downward rating action:
­Revenue declined to Rs.70 crore or below
Movement in financial risk profile and any significant elongation in GCA days 
Liquidity Position
Stretched

The company has stretched liquidity marked by net cash accruals of Rs. 2.24 Cr. as on FY2025 as against debt obligation of Rs. 0.45 Cr. over the same period. NCA is expected to be in the range of Rs. 1.75 to Rs.2.50 crore against nil debt obligation. The cash and bank balance stood at Rs. 0.55 Cr. for FY 2025. Further, the current ratio of the company stood at 1.36 times in FY2025. The bank limit of the company stood very high at 98.00 percent utilized for the last six months ended Mar 2026. Average non fund base utilization stood at 80%. Acuité believes that the liquidity of the company is likely to improve over the medium term supported by increase in accruals and absence of debt funded capex plan.

 
Outlook: Stable
­
 
Other Factors affecting Rating
­None
 

Particulars Unit FY 25 (Actual) FY 24 (Actual)
Operating Income Rs. Cr. 114.08 103.03
PAT Rs. Cr. 1.54 1.42
PAT Margin (%) 1.35 1.38
Total Debt/Tangible Net Worth Times 0.36 0.34
PBDIT/Interest Times 2.66 2.37
Status of non-cooperation with previous CRA (if applicable)
­Not Applicable
 
Any other information
­None
 
Applicable Criteria
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm

Note on complexity levels of the rated instrument

Date Name of Instruments/Facilities Term Amount (Rs. Cr) Rating/Outlook
20 Jan 2025 Bank Guarantee (BLR) Short Term 24.00 ACUITE A4 (Reaffirmed)
Cash Credit Long Term 6.00 ACUITE B+ | Stable (Upgraded from ACUITE B- | Stable)
Working Capital Term Loan Long Term 0.75 ACUITE B+ | Stable (Upgraded from ACUITE B- | Stable)
Proposed Long Term Bank Facility Long Term 19.25 ACUITE B+ | Stable (Upgraded from ACUITE B- | Stable)
31 Oct 2023 Bank Guarantee (BLR) Short Term 24.00 ACUITE A4 (Reaffirmed)
Cash Credit Long Term 6.00 ACUITE B- | Stable (Upgraded from ACUITE C)
Working Capital Term Loan Long Term 0.60 ACUITE B- | Stable (Upgraded from ACUITE C)
Working Capital Term Loan Long Term 0.75 ACUITE B- | Stable (Upgraded from ACUITE C)
Term Loan Long Term 0.35 ACUITE B- | Stable (Upgraded from ACUITE C)
Proposed Long Term Bank Facility Long Term 18.30 ACUITE B- | Stable (Upgraded from ACUITE C)
31 Jan 2023 Bank Guarantee (BLR) Short Term 18.00 ACUITE A4 (Reaffirmed)
Bank Guarantee (BLR) Short Term 6.00 ACUITE A4 (Assigned)
Cash Credit Long Term 6.00 ACUITE C (Downgraded from ACUITE B+ | Stable)
Proposed Long Term Bank Facility Long Term 1.00 ACUITE C (Downgraded from ACUITE B+ | Stable)
Working Capital Demand Loan (WCDL) Long Term 1.80 ACUITE C (Downgraded from ACUITE B+ | Stable)
Covid Emergency Line. Long Term 0.75 ACUITE C (Assigned)
Term Loan Long Term 0.42 ACUITE C (Assigned)
Proposed Long Term Bank Facility Long Term 16.03 ACUITE C (Assigned)
­

Lender’s Name ISIN Facilities Date Of Issuance Coupon Rate Maturity Date Quantum
(Rs. Cr.)
Complexity Level Rating
Canara Bank Not avl. / Not appl. Bank Guarantee (BLR) Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 24.00 Simple ACUITE A4+ | Upgraded ( from ACUITE A4 )
Canara Bank Not avl. / Not appl. Cash Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 6.00 Simple ACUITE BB- | Stable | Upgraded ( from ACUITE B+ )
Not Applicable Not avl. / Not appl. Proposed Long Term Bank Facility Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 2.25 Simple ACUITE BB- | Stable | Upgraded ( from ACUITE B+ )
Not Applicable Not avl. / Not appl. Proposed Long Term Bank Facility Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 17.00 Simple ACUITE Not Applicable | Withdrawn
Canara Bank Not avl. / Not appl. Working Capital Term Loan Not avl. / Not appl. Not avl. / Not appl. 31 Dec 2026 0.75 Simple ACUITE BB- | Stable | Upgraded ( from ACUITE B+ )

Contacts

List of instruments and names of regulators of the instruments
As required by SEBI Circular (SEBI/HO/DDHS/DDHS-PoD-2/I/4685/2026) dated February 10, 2026, a list of activities or instruments falling under the purview of various Financial Sector Regulators (FSRs), along with the names of respective FSRs, is being disclosed below:
A. Rating Activity:

 
Sr. No. Instrument / activity Name Regulator of the instrument
1 Listed/Proposed to be listed Bonds/Debentures/Preference Shares (all securities) SEBI
2 Unlisted/Proposed to be unlisted Bonds/Debentures/ Preference share (all securities) MCA
3 Listed PTCs / Securitisation Notes (originated by entities regulated by RBI)1 SEBI
4 Listed PTCs / Securitisation Notes (originated by entities not regulated by RBI)1 SEBI
5 Unlisted PTCs / Securitisation Notes (originated by entities regulated by RBI)1 RBI
6 Listed Commercial Paper and NCDs with original maturity less than 1 year RBI
7 Unlisted Commercial Paper and NCDs with original maturity less than 1 year RBI
8 Loan Facilities (Fund/Non-Fund Based) from Bank / NBFCs/ NHB/ FIs 2 RBI
9 External Commercial Borrowings and other similar borrowings RBI
10 Certificates of Deposit RBI
11 Fixed Deposits raised by NBFCs, Banks, HFCs, FIs RBI
12 Fixed Deposits raised by corporates other than NBFCs, Banks, HFCs, FIs MCA
13 Inter Corporate Deposits/Loans extended by Corporates MCA
14 Borrowing programme 3 -
15 Issuer Ratings 4 -
16 Credit Ratings for Capital Protection Oriented Schemes (by Mutal Funds and AIFs) SEBI
17 Credit quality ratings (CQRs) for Mutual Fund Schemes and Schemes of AIFs SEBI
18 Listed Security Receipts SEBI
19 Unlisted Security Receipts RBI
20 Independent Credit Evaluation (ICE) RBI
21 Expected Loss Ratings (For Loan Facilities [Fund/Non-Fund based] from Banks/NBFCs/NHB/FIs) RBI
22 Expected Loss Ratings (Listed / Proposed to be listed Bonds / Debentures / Preference Shares (all securities)) SEBI
23 Expected Loss Ratings (Unlisted / Proposed to be unlisted Bonds/ Debentures / Preference Shares (all securities)) MCA
24 Unlisted PTCs / Securitisation Notes (originated by entities not regulated by RBI) 1 Investor-side Regulator such as IRDAI, PFRDA 5
 
Includes securitisation transactions involving assignee payout, acquirer's payout.
2 Includes bank facilities such as liquidity facility, second loss facility that are part of securitisation transactions.
There is no instrument being rated and hence, Regulator of the Instrument is not applicable. The rating scale and definitions are being followed as stipulated in SEBI Master Circular for CRAs.
4 The rated instrument may involve issuance of different instruments such as debt securities (listed or otherwise), bank loans, commercial paper (listed or otherwise), etc. The regulator of the instrument may accordingly be SEBI, RBI or MCA and can only be determined upon issuance. In Press Release(s) subsequent to issuance(s), Acuite shall separately capture the rated quantum details along with names of respective regulators.
5 These ratings were assigned during regulatory regime prior to the introduction of SEBI CRA Circular dated Feb 10, 2026 and accordingly, investor side regulators have been included.

 
B. Other activities:
 
Sr. No. Activity Name Regulator of the activity
1 Monitoring Agency SEBI
2 Research activities, incidental to rating, such as research for Economy, Industries and Companies 6 Not applicable
6 permitted by SEBI vide SEBI Master Circular for CRAs.

Disclosure on instruments / activities and names of regulators:
A list of products/activities or ratings of instruments falling under the purview of various financial sector regulators (FSRs) along with the names of respective FSRs has also been duly disclosed by Acuite on its website. A link to the same has been provided below for ready reference:

About Acuité Ratings & Research

© Acuité Ratings & Research Limited. All Rights Reserved.www.acuite.in